GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Total Long-Term Liabilities

CVALF (Covalon Technologies) Total Long-Term Liabilities : $0.08 Mil (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Covalon Technologies's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was $0.08 Mil.

Covalon Technologies Total Long-Term Liabilities Historical Data

The historical data trend for Covalon Technologies's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Total Long-Term Liabilities Chart

Covalon Technologies Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.23 1.75 1.21 0.68 0.23

Covalon Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.30 0.23 0.15 0.08

Covalon Technologies Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Covalon Technologies Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Covalon Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Total Long-Term Liabilities
Comparable Companies
XCNQ:GLAB TSX:MDNA TSX:SVA NEOE:ONCO TSXV:MIR TSXV:NRX TSXV:SHRX TSX:HBP TSX:ONC TSX:MBX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
COV:Canada
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Website
https://www.covalon.com
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.